Enabling superior drug loading in lipid-based formulations with lipophilic salts for a brick dust molecule: Exploration of lipophilic counterions and in vitro-in vivo evaluation

被引:5
作者
Sirvi, Arvind [1 ]
Jadhav, Karan [1 ]
Sangamwar, Abhay T. [1 ]
机构
[1] Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut, Sect 67, SAS Nagar, Punjab, India
关键词
Lipophilic salt; Complexation; Drug loading; Supersaturation; Digestion diffusion setup; Brick dust molecule; WATER-SOLUBLE DRUGS; IONIC LIQUIDS; DELIVERY; SUPERSATURATION; ABSORPTION; BIOAVAILABILITY; PERFORMANCE; STABILITY; SEDDS;
D O I
10.1016/j.ijpharm.2024.124108
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lipid-based formulations (LbFs) are an extensively used approach for oral delivery of poorly soluble drug compounds in the form of lipid suspension and lipid solution. However, the high target dose and inadequate lipid solubility limit the potential of brick dust molecules to be formulated as LbFs. Thus, the complexation of such molecules with a lipophilic counterion can be a plausible approach to improve the solubility in lipid-based solutions via reducing drug crystallinity and polar surface area. The study aimed to enhance drug loading in lipid solution for Nilotinib (Nil) through complexation or salt formation with different lipophilic counterions. We synthesized different lipophilic salts/ complexes via metathesis reactions and confirmed their formation by 1H NMR and FTIR. Docusate-based lipophilic salt showed improved solubility in medium-chain triglycerides (-7 to 7.5-fold) and long-chain triglycerides (-30 to 35-fold) based lipids compared to unformulated crystalline Nil. The increased lipid solubility could be attributed to the reduction in drug crystallinity which was further confirmed by the PXRD and DSC. Prototype LbFs were prepared to evaluate drug loading and their physicochemical characteristics. The findings suggested that structural features of counterion including chain length and lipophilicity affect the drug loading in LbF. In addition, physical stability testing of formulations was performed, inferring that aliphatic sulfate-based LbFs were stable with no sign of drug precipitation or salt disproportionation. An in vitro lipolysis-permeation study revealed that the primary driver of absorptive flux is the solubilization of the drug and reduced amount of lipid. Further, the in vivo characterization was conducted to measure the influence of increased drug load on oral bioavailability. Overall, the results revealed enhanced absorption of lipophilic salt-based LbF over unformulated crystalline Nil and conventional LbF (drug load equivalent to equilibrium solubility) which supports the idea that lipophilic salt-based LbF enhances drug loading, and supersaturation-mediated drug solubilization, unlocking the full potential of LbF.
引用
收藏
页数:17
相关论文
共 57 条
[1]   Models for Predicting Drug Absorption From Oral Lipid-Based Formulations [J].
Linda C. Alskär ;
Christel A. S. Bergström .
Current Molecular Biology Reports, 2015, 1 (4) :141-147
[2]   Lipid Digestion as a Trigger for Supersaturation: Evaluation of the Impact of Supersaturation Stabilization on the in Vitro and in Vivo Performance of Self-Emulsifying Drug Delivery Systems [J].
Anby, Mette U. ;
Williams, Hywel D. ;
McIntosh, Michelle ;
Benameur, Hassan ;
Edwards, Glenn A. ;
Pouton, Colin W. ;
Porter, Christopher J. H. .
MOLECULAR PHARMACEUTICS, 2012, 9 (07) :2063-2079
[3]   Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility-Permeability Interplay [J].
Beig, Avital ;
Lindley, David ;
Miller, Jonathan M. ;
Agbaria, Riad ;
Dahan, Arik .
FRONTIERS IN PHARMACOLOGY, 2016, 7
[4]   Computational prediction of formulation strategies for beyond-rule-of-5 compounds [J].
Bergstrom, Christel A. S. ;
Charman, William N. ;
Porter, Christopher J. H. .
ADVANCED DRUG DELIVERY REVIEWS, 2016, 101 :6-21
[5]   Carboxylic Acid Counterions in FDA-Approved Pharmaceutical Salts [J].
Bharate, Sonali S. .
PHARMACEUTICAL RESEARCH, 2021, 38 (08) :1307-1326
[6]   Simultaneous lipolysis/permeation in vitro model, for the estimation of bioavailability of lipid based drug delivery systems [J].
Bibi, Hanady Ajine ;
Holm, Rene ;
Bauer-Brandl, Annette .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2017, 117 :300-307
[7]   Pharmaceutically active ionic liquids with solids handling, enhanced thermal stability, and fast release [J].
Bica, Katharina ;
Rodriguez, Hector ;
Gurau, Gabriela ;
Cojocaru, O. Andreea ;
Riisager, Anders ;
Fehrmann, Rasmus ;
Rogers, Robin D. .
CHEMICAL COMMUNICATIONS, 2012, 48 (44) :5422-5424
[8]   Enhanced biopharmaceutical performance of brick dust molecule nilotinib via stabilized amorphous nanosuspension using a facile acid-base neutralization approach [J].
Chougule, Mahendra ;
Sirvi, Arvind ;
Saini, Vanshul ;
Kashyap, Mahesh ;
Sangamwar, Abhay T. .
DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2023, 13 (10) :2503-2519
[9]   Transient Supersaturation Supports Drug Absorption from Lipid-Based Formulations for Short Periods of Time, but Ongoing Solubilization Is Required for Longer Absorption Periods [J].
Crum, Matthew F. ;
Trevaskis, Natalie L. ;
Pouton, Colin W. ;
Porter, Christopher J. H. .
MOLECULAR PHARMACEUTICS, 2017, 14 (02) :394-405
[10]   Task-specific ionic liquids [J].
Davis, JH .
CHEMISTRY LETTERS, 2004, 33 (09) :1072-1077